![]() | EXHIBIT 99.1 | |||
2Q 2026 Earnings Release | ||||
FOR IMMEDIATE RELEASE | July 31, 2026 | |||
Results Summary | ||||||
2Q26 | 1Q26 | Change vs 1Q26 | Dollars in millions (except per share data) | YTD 2026 | YTD 2025 | Change vs YTD 2025 |
14,525 | 4,183 | +10,342 | Earnings (U.S. GAAP) | 18,708 | 14,795 | +3,913 |
14,680 | 8,772 | +5,908 | Adjusted Earnings/(Loss) (non-GAAP) | 23,452 | 14,555 | +8,897 |
3.48 | 1.00 | +2.48 | Earnings Per Common Share (U.S. GAAP) ¹ | 4.47 | 3.40 | +1.07 |
3.52 | 2.09 | +1.43 | Adjusted Earnings/(Loss) Per Common Share (non-GAAP) ¹ | 5.60 | 3.35 | +2.25 |
![]() | ||||
EARNINGS AND VOLUME SUMMARY BY SEGMENT | ||||
2Q26 | 1Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
Earnings/(Loss) (U.S. GAAP) | ||||
7,927 | 5,737 | Upstream | 13,664 | 12,158 |
5,465 | (1,262) | Energy Products | 4,203 | 2,193 |
1,131 | 110 | Chemical Products | 1,241 | 566 |
956 | 651 | Specialty Products | 1,607 | 1,435 |
(954) | (1,053) | Corporate and Financing | (2,007) | (1,557) |
14,525 | 4,183 | Total Earnings/(Loss) (U.S. GAAP) | 18,708 | 14,795 |
Adjusted Earnings/(Loss) (non-GAAP) | ||||
9,189 | 6,265 | Upstream | 15,454 | 11,880 |
4,099 | 2,799 | Energy Products | 6,898 | 2,231 |
1,214 | 110 | Chemical Products | 1,324 | 566 |
969 | 651 | Specialty Products | 1,620 | 1,435 |
(791) | (1,053) | Corporate and Financing | (1,844) | (1,557) |
14,680 | 8,772 | Total Adjusted Earnings/(Loss) (non-GAAP) | 23,452 | 14,555 |
Volumes | ||||
4,514 | 4,594 | Production (koebd) | 4,554 | 4,591 |
5,698 | 5,630 | Energy Products Sales (kbd) | 5,664 | 5,436 |
4,471 | 5,358 | Chemical Products Sales (kt) | 9,829 | 10,040 |
1,784 | 1,976 | Specialty Products Sales (kt) | 3,760 | 3,940 |
![]() | ||||
CASH FLOW FROM OPERATIONS EXCLUDING WORKING CAPITAL | ||||
2Q26 | 1Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
14,881 | 4,472 | Net income/(loss) including noncontrolling interests | 19,353 | 15,387 |
8,689 | 6,771 | Depreciation and depletion (includes impairments) | 15,460 | 11,803 |
(2,099) | (1,758) | Changes in operational working capital, excluding cash and debt | (3,857) | (4,848) |
2,084 | (780) | Other | 1,304 | 2,161 |
23,555 | 8,705 | Cash Flow from Operating Activities (U.S. GAAP) | 32,260 | 24,503 |
2,099 | 1,758 | Less: Changes in operational working capital, excluding cash and debt | 3,857 | 4,848 |
25,654 | 10,463 | Cash Flow from Operations excluding Working Capital (non-GAAP) | 36,117 | 29,351 |
FREE CASH FLOW | ||||
2Q26 | 1Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
23,555 | 8,705 | Cash Flow from Operating Activities (U.S. GAAP) | 32,260 | 24,503 |
(6,527) | (6,470) | Additions to property, plant, and equipment | (12,997) | (12,181) |
(324) | (387) | Additional investments and advances | (711) | (472) |
102 | 632 | Other investing activities including collection of advances | 734 | 339 |
430 | 219 | Proceeds from asset sales and returns of investments | 649 | 1,999 |
— | — | Inflows from noncontrolling interest for major projects | — | 45 |
17,236 | 2,699 | Free Cash Flow (non-GAAP) | 19,935 | 14,233 |
![]() | ||||
CASH CAPITAL EXPENDITURES | ||||
2Q26 | 1Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
6,527 | 6,470 | Additions to property, plant, and equipment | 12,997 | 12,181 |
324 | 387 | Additional investments and advances | 711 | 472 |
(102) | (632) | Other investing activities including collection of advances | (734) | (339) |
— | — | Inflows from noncontrolling interests for major projects | — | (45) |
38 | (38) | Less: Advances and collections not related to capital expenditures or equity investments | — | 270 |
6,787 | 6,187 | Total Cash Capital Expenditures (non-GAAP) | 12,974 | 12,539 |
2Q26 | 1Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
Upstream | ||||
3,423 | 3,449 | United States | 6,872 | 6,390 |
2,429 | 1,363 | Non-U.S. | 3,792 | 4,272 |
5,852 | 4,812 | Total | 10,664 | 10,662 |
Energy Products | ||||
331 | 828 | United States | 1,159 | 281 |
196 | 170 | Non-U.S. | 366 | 529 |
527 | 998 | Total | 1,525 | 810 |
Chemical Products | ||||
263 | 156 | United States | 419 | 325 |
44 | 26 | Non-U.S. | 70 | 245 |
307 | 182 | Total | 489 | 570 |
Specialty Products | ||||
18 | 35 | United States | 53 | 95 |
(7) | 20 | Non-U.S. | 13 | 112 |
11 | 55 | Total | 66 | 207 |
Other | ||||
90 | 140 | Other | 230 | 290 |
6,787 | 6,187 | Worldwide | 12,974 | 12,539 |
![]() | ||||||
CALCULATION OF STRUCTURAL COST SAVINGS | ||||||
Dollars in billions (unless otherwise noted) | Twelve Months Ended December 31, | Six Months Ended June 30, | ||||
2019 | 2025 | 2025 | 2026 | |||
Components of Operating Costs | ||||||
From ExxonMobil’s Consolidated Statement of Income (U.S. GAAP) | ||||||
Production and manufacturing expenses | 36.8 | 42.4 | 20.2 | 22.9 | ||
Selling, general and administrative expenses | 11.4 | 11.1 | 5.1 | 5.2 | ||
Depreciation and depletion (includes impairments) | 19.0 | 26.0 | 11.8 | 15.5 | ||
Exploration expenses, including dry holes | 1.3 | 1.0 | 0.3 | 0.3 | ||
Non-service pension and postretirement benefit expense | 1.2 | 0.4 | 0.2 | 0.1 | ||
Subtotal | 69.7 | 81.0 | 37.6 | 43.9 | ||
ExxonMobil’s share of equity company expenses (non-GAAP) | 9.1 | 10.6 | 5.2 | 4.3 | ||
Total Adjusted Operating Costs (non-GAAP) | 78.8 | 91.6 | 42.8 | 48.2 | ||
Total Adjusted Operating Costs (non-GAAP) | 78.8 | 91.6 | 42.8 | 48.2 | ||
Less: | ||||||
Depreciation and depletion (includes impairments) | 19.0 | 26.0 | 11.8 | 15.5 | ||
Non-service pension and postretirement benefit expense | 1.2 | 0.4 | 0.2 | 0.1 | ||
Other adjustments (includes equity company depreciation and depletion) | 3.6 | 6.2 | 2.4 | 4.2 | ||
Total Cash Operating Expenses (Cash Opex) (non-GAAP) | 55.0 | 59.0 | 28.4 | 28.5 | ||
Energy and production taxes (non-GAAP) | 11.0 | 14.9 | 7.6 | 6.6 | ||
Total Cash Operating Expenses (Cash Opex) excluding Energy and Production Taxes (non-GAAP) | 44.0 | 44.1 | 20.8 | 21.9 | ||
Change vs 2019 | Change vs 2025 | Estimated Cumulative vs 2019 | ||||
Total Cash Operating Expenses (Cash Opex) excluding Energy and Production Taxes (non-GAAP) | +0.1 | +1.1 | ||||
Market | +4.9 | +0.9 | ||||
Activity/ Other | +10.3 | +1.4 | ||||
Structural Cost Savings | -15.1 | -1.2 | -16.3 | |||
![]() | ||||
KEY FIGURES: ADJUSTING ITEMS | ||||
2Q26 | 1Q26 | Dollars in millions (unless otherwise noted) | YTD 2026 | YTD 2025 |
14,525 | 4,183 | Earnings/(Loss) (U.S. GAAP) | 18,708 | 14,795 |
Identified Items | ||||
(1,079) | — | Impairments | (1,079) | — |
(1,559) | (706) | Other ¹ | (2,265) | — |
(2,638) | (706) | Total Identified Items | (3,344) | — |
2,483 | (3,883) | Estimated Timing Effects | (1,400) | 240 |
14,680 | 8,772 | Adjusted Earnings/(Loss) (non-GAAP) | 23,452 | 14,555 |
1 2Q26 Other Identified Items includes $1,365 million in additions to financial reserves and $194 million in Middle East impacts; 1Q26 includes $706 million in Middle East impacts. | ||||
ADJUSTING ITEMS PER COMMON SHARE | ||||
2Q26 | 1Q26 | Dollars per common share | YTD 2026 | YTD 2025 |
3.48 | 1.00 | Earnings/(Loss) Per Common Share (U.S. GAAP) ¹ | 4.47 | 3.40 |
Identified Items Per Common Share ¹ | ||||
(0.26) | — | Impairments | (0.26) | — |
(0.37) | (0.16) | Other | (0.54) | — |
(0.63) | (0.16) | Total Identified Items Per Common Share ¹ | (0.80) | — |
0.59 | (0.92) | Estimated Timing Effects Per Common Share ¹ | (0.33) | 0.06 |
3.52 | 2.09 | Adjusted Earnings/(Loss) Per Common Share (non-GAAP) ¹ | 5.60 | 3.35 |
¹ Assuming dilution. | ||||
![]() | ||||||||||
KEY FIGURES: ADJUSTING ITEMS BY SEGMENT | ||||||||||
Second Quarter 2026 | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate & Financing | Total | ||||
Dollars in millions (unless otherwise noted) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | ||
Earnings/(Loss) (U.S. GAAP) | 1,920 | 6,007 | 2,987 | 2,478 | 599 | 532 | 287 | 669 | (954) | 14,525 |
Identified Items | ||||||||||
Impairments | — | — | — | (884) | (48) | — | — | — | (147) | (1,079) |
Other ¹ | (1,183) | (16) | (49) | (247) | (6) | (29) | (2) | (11) | (16) | (1,559) |
Total Identified Items | (1,183) | (16) | (49) | (1,131) | (54) | (29) | (2) | (11) | (163) | (2,638) |
Estimated Timing Effects (Worldwide) | (63) | 2,546 | — | — | — | 2,483 | ||||
Adjusted Earnings/(Loss) (non-GAAP) | 9,189 | 4,099 | 1,214 | 969 | (791) | 14,680 | ||||
¹ 2Q26 Other Identified Items includes $1,365 million in additions to financial reserves and $194 million in Middle East impacts | ||||||||||
First Quarter 2026 | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate & Financing | Total | ||||
Dollars in millions (unless otherwise noted) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | ||
Earnings/(Loss) (U.S. GAAP) | 1,574 | 4,163 | 661 | (1,923) | 319 | (209) | 274 | 377 | (1,053) | 4,183 |
Identified Items | ||||||||||
Other ¹ | — | — | — | (706) | — | — | — | — | — | (706) |
Total Identified Items | — | — | — | (706) | — | — | — | — | — | (706) |
Estimated Timing Effects (Worldwide) | (528) | (3,355) | — | — | — | (3,883) | ||||
Adjusted Earnings/(Loss) (non-GAAP) | 6,265 | 2,799 | 110 | 651 | (1,053) | 8,772 | ||||
¹ 1Q26 Other Identified Items includes $706 million in Middle East impacts. | ||||||||||
YTD 2026 | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate & Financing | Total | ||||
Dollars in millions (unless otherwise noted) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | ||
Earnings/(Loss) (U.S. GAAP) | 3,494 | 10,170 | 3,648 | 555 | 918 | 323 | 561 | 1,046 | (2,007) | 18,708 |
Identified Items | ||||||||||
Impairments | — | — | — | (884) | (48) | — | — | — | (147) | (1,079) |
Other ¹ | (1,183) | (16) | (49) | (953) | (6) | (29) | (2) | (11) | (16) | (2,265) |
Total Identified Items | (1,183) | (16) | (49) | (1,837) | (54) | (29) | (2) | (11) | (163) | (3,344) |
Estimated Timing Effects (Worldwide) | (591) | (809) | — | — | — | (1,400) | ||||
Adjusted Earnings/(Loss) (non-GAAP) | 15,454 | 6,898 | 1,324 | 1,620 | (1,844) | 23,452 | ||||
¹ YTD 2026 Other Identified Items includes $1,365 million in additions to financial reserves and $900 million in Middle East impacts | ||||||||||
YTD 2025 | Upstream | Energy Products | Chemical Products | Specialty Products | Corporate & Financing | Total | ||||
Dollars in millions (unless otherwise noted) | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | U.S. | Non-U.S. | ||
Earnings/(Loss) (U.S. GAAP) | 3,082 | 9,076 | 1,122 | 1,071 | 510 | 56 | 613 | 822 | (1,557) | 14,795 |
Total Identified Items | — | — | — | — | — | — | — | — | — | — |
Estimated Timing Effects (Worldwide) | 278 | (38) | — | — | — | 240 | ||||
Adjusted Earnings/(Loss) (non-GAAP) | 11,880 | 2,231 | 566 | 1,435 | (1,557) | 14,555 | ||||